Mario Eisenberger

Professor

1977 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mario Eisenberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Survival Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2019

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

McHugh, D., Eisenberger, M., Heath, E. I., Bruce, J., Danila, D. C., Rathkopf, D. E., Feldman, J., Slovin, S. F., Anand, B., Chu, R., Lackey, J., Reyno, L., Antonarakis, E. & Morris, M. J., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Maximum Tolerated Dose
Antibodies
Fatigue

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer

Paller, C., Piana, D., Eshleman, J., Riel, S., Denmeade, S. R., Isaacsson Velho, P., Rowe, S., Pomper, M. G., Antonarakis, E., Luo, J. & Eisenberger, M., Jan 1 2019, In : Prostate. 79, 14, p. 1597-1603 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Circulating Neoplastic Cells
Therapeutics
Castration
Prostate-Specific Antigen

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

Marshall, C. H., Sokolova, A. O., McNatty, A. L., Cheng, H. H., Eisenberger, M., Bryce, A. H., Schweizer, M. T. & Antonarakis, E., Jan 1 2019, In : European Urology.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Mutation
Therapeutics
olaparib

Expression of AR-V7 and ARV 567Es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in taxynergy

Tagawa, S. T., Antonarakis, E., Gjyrezi, A., Galletti, G., Kim, S., Worroll, D., Stewart, J., Zaher, A., Szatrowski, T. P., Ballman, K. V., Kita, K., Tasaki, S., Bai, Y., Portella, L., Kirby, B. J., Saad, F., Eisenberger, M., Nanus, D. M. & Giannakakou, P., Jan 1 2019, In : Clinical Cancer Research. 25, 6, p. 1880-1888 9 p.

Research output: Contribution to journalArticle

Open Access
Circulating Neoplastic Cells
Androgen Receptors
Prostatic Neoplasms
Therapeutics
taxane

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype

Shenderov, E., Isaacsson Velho, P., Awan, A. H., Wang, H., Mirkheshti, N., Lotan, T., Carducci, M. A., Pardoll, A. M., Eisenberger, M. & Antonarakis, E., Jan 1 2019, In : Prostate. 79, 13, p. 1572-1579 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Androgens
Prostate-Specific Antigen
Lung
Hormones